CD24Fc to DAMPen GVHD
- PMID: 38175676
- DOI: 10.1182/blood.2023022228
CD24Fc to DAMPen GVHD
Comment on
-
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease.Blood. 2024 Jan 4;143(1):21-31. doi: 10.1182/blood.2023020250. Blood. 2024. PMID: 37647633 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

